344
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Differences in the Spirometry Parameters Between Indigenous and Non-Indigenous Patients with COPD: A Matched Control Study

, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 869-881 | Published online: 21 Apr 2022

References

  • Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://www.goldcopd.org. Accessed March 27, 2022.
  • Toelle BG, Xuan W, Bird TE, et al. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust. 2013;198(3):144–148. doi:10.5694/mja11.11640
  • Yang IA, George J, Jenkins S, et al. The COPD-X plan: Australian and New Zealand guidelines for the management of Chronic Obstructive Pulmonary Disease 2021. Version 2.63; February, 2021. Available from: https://copdx.org.au. Accessed March 27, 2022.
  • Australian Institute of Health and Welfare. Chronic obstructive pulmonary disease (COPD). Cat. no. ACM 35. Canberra: AIHW; 2020. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/copd. Accessed March 27, 2022.
  • Australian Institute of Health and Welfare. Deaths in Australia. Cat. no. PHE 229. Canberra: AIHW; 2021. Available from: https://www.aihw.gov.au/reports/life-expectancy-death/deaths-in-australia. Accessed March 27, 2022.
  • Australian Bureau of Statistics. Estimates of Aboriginal and Torres Strait Islander Australians. Canberra, Australia: ABS; 2016.
  • Mehra S, Chang AB, Lam CK, et al. Bronchiectasis among Australian aboriginal and non-aboriginal patients in the regional and remote population of the Northern Territory of Australia. Rural Remote Health. 2021;21(2):6390. doi:10.22605/RRH6390
  • Heraganahally SS, Timothy TP, Sorger L. Chest computed tomography findings among adult Indigenous Australians in the Northern Territory of Australia. J Med Imaging Radiat Oncol. 2021;66(3):337–344. doi:10.1111/1754-9485.13295
  • Kruavit A, Fox M, Pearson R, Heraganahally S. Chronic respiratory disease in the regional and remote population of the Northern Territory Top End: a perspective from the specialist respiratory outreach service. Aust J Rural Health. 2017;25(5):275–284. doi:10.1111/ajr.12349
  • Heraganahally S, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease in aboriginal patients of The Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis. 2019;14:2205–2217. doi:10.2147/COPD.S213947
  • Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease with and without bronchiectasis in aboriginal Australians – a comparative study. Int Med J. 2020;50(12):1505–1513. doi:10.1111/imj.14718
  • Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80(2):84–90.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. “ATS/ERS task force: standardisation of lung function testing”. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Schubert J, Kruavit A, Mehra S, Wasgewatta S, Chang AB, Heraganahally S. Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory. Int Med J. 2019;49(2):217–224. doi:10.1111/imj.14112
  • Heraganahally SS, Ponneri TR, Howarth TP, Saad HB. The effects of inhaled airway directed pharmacotherapy on decline in lung function parameters among indigenous Australian adults with and without underlying airway disease. Int J Chron Obstruct Pulmon Dis. 2021;16:2707–2720. doi:10.2147/COPD.S328137
  • Heraganahally SS, Howarth T, Mo L, Sorger L, Saad HB. Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases. Expert Rev Respir Med. 2021;15(9):1229–1238. doi:10.1080/17476348.2021.1928496
  • Howarth TP, Saad HB, Perez AJ, Atos CB, White E, Heraganahally SS. Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults. PLoS One. 2021;16(4):e0248900. doi:10.1371/journal.pone.0248900
  • de Hamel FA, Glass WJ. Observations on Maori-European lung function differences. Aust N Z J Med. 1975;5(1):44–48. doi:10.1111/j.1445-5994.1975.tb03254.x
  • Cooksley NA, Atkinson D, Marks GB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross-sectional BOLD study. Respirology. 2015;20(5):766–774. doi:10.1111/resp.12482
  • Veale AJ, Peat JK, Salome CM, Woolcock AJ, Thompson JE. ‘Normal’ lung function in rural Australian aborigines. Aust N Z J Med. 1997;27(5):543–549. doi:10.1111/j.1445-5994.1997.tb00962.x
  • Heraganahally SS, Howarth T, White E, Sorger L, Biancardi E, Ben Saad H. Lung function parameters among Australian Aboriginal “apparently healthy” adults: an Australian Caucasian and global lung function initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med. 2020;23:1–11. doi:10.1080/17476348.2021.1847649
  • Heraganahally S, Howarth TP, White E, Ben Saad H. Implications of using the GLI-2012, GOLD and Australian COPD-X recommendations in assessing the severity of airflow limitation on spirometry among an Indigenous population with COPD: an Indigenous Australians perspective study. BMJ Open Respir Res. 2021;8(1):e001135. doi:10.1136/bmjresp-2021-001135
  • National Health and Medical Research Council. Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and communities: guidelines for researchers and stakeholders. Canberra: Commonwealth of Australia; 2018.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
  • Olejnik S, Algina J. Measures of effect size for comparative studies: applications, interpretations, and limitations. Contemp Educ Psychol. 2000;25(3):241–286. doi:10.1006/ceps.2000.1040
  • State of the world’s Indigenous peoples. Indigenous peoples’ access to health services. United nations; 2018. Available from: https://www.un.org/development/desa/indigenouspeoples/wp-content/uploads/sites/19/2018/03/The-State-of-The-Worlds-Indigenous-PeoplesWEB.pdf. Accessed March 27, 2022.
  • Bird Y, Moraros J, Mahmood R, et al. Prevalence and associated factors of COPD among Aboriginal peoples in Canada: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;30(12):1915–1922. doi:10.2147/COPD.S138304
  • Australian institute of health and welfare. Indigenous Australians more likely to die from CHD and COPD, but some positive trends emerging - Australian Institute of Health and Welfare; 2014. Available from: https://www.aihw.gov.au/news-media/media-releases/2014/june/indigenous-australians-more-likely-to-die-from-chd. Accessed March 27, 2022.
  • Ospina MB, Voaklander DC, Stickland MK. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J. 2012;19(6):355–360. doi:10.1155/2012/825107
  • White E, James A, de Klerk N, Musk A, Hall G. Selection of appropriate spirometry reference values in Aboriginal Australians. Australian Indigenous Health Bulletin; 2019;19.
  • Hall GL, Pearson G. Reduced forced vital capacity in Aboriginal Australians: biology or missing evidence? Respirology. 2015;20(5):693–694. doi:10.1111/resp.12552
  • Martinez-Pitre PJ, Sabbula BR, Cascella M. Restrictive lung disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [Updated July 31, 2021]. Available from https://www.ncbi.nlm.nih.gov/books/NBK560880/. Accessed March 27, 2022.
  • Obaseki DO, Erhabor GE, Awopeju OF, et al. Reduced forced vital capacity in an African population. Prevalence and risk factors. Ann Am Thorac Soc. 2017;14(5):714–721. doi:10.1513/AnnalsATS.201608-598OC
  • Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J. 2010;36(1):12–19. doi:10.1183/09031936.00143209
  • Kumar R, Seibold MA, Aldrich MC, et al. Genetic ancestry in lung-function predictions. N Engl J Med. 2010;363(4):321–330. doi:10.1056/NEJMoa0907897
  • Braun L, Wolfgang M, Dickersin K. Defining race/ethnicity and explaining difference in research studies on lung function. Eur Respir J. 2013;41(6):1362–1370. doi:10.1183/09031936.00091612
  • Westrupp EM, D’Esposito F, Freemantle J, Mensah FK, Nicholson JM. Health outcomes for Australian Aboriginal and Torres Strait Islander children born preterm, low birthweight or small for gestational age: a nationwide cohort study. PLoS One. 2019;14(2):e0212130. doi:10.1371/journal.pone.0212130
  • Gaultier C, Crapo R. Effects of nutrition, growth hormone disturbances, training, altitude and sleep on lung volumes. Eur Respir J. 1997;10(12):2913–2919. doi:10.1183/09031936.97.10122913
  • Howarth T, Brunette R, Davies T, et al. Antibiotic use for Australian Aboriginal children in three remote Northern Territory communities. PLoS One. 2020;15(4):e0231798. doi:10.1371/journal.pone.0231798
  • Fenton ME, Graham BL, Stanojevic S, Whitford L, Ironstand L. Interpretation of Spirometry in Saskatchewan First Nations Adults. Ann ATS. 2018;15(10):1237–1239. doi:10.1513/AnnalsATS.201711-909RL
  • Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483
  • Hoesein FAAM, Zanen P, Lammers JJ. Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based review. Respir Med. 2011;105(6):907–915. doi:10.1016/j.rmed.2011.01.008
  • Dijk WV, Tan W, Li P, et al. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort. Ann Fam Med. 2015;13(1):41–48. doi:10.1370/afm.1714
  • Stanojevic S, Kaminsky DA, Miller M, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2021:2101499. doi:10.1183/13993003.01499-2021.
  • Blake TL, Chang AB, Petsky HL, et al. Spirometry reference values in Indigenous Australians: a systematic review. Med J Aust. 2016;205(1):35–40. doi:10.5694/mja16.00226
  • Stepwise management of stable COPD. Lung Foundation Australia; 2021. Available from https://lungfoundation.com.au/resources/stepwise-management-of-stable-copd/. Accessed March 27, 2022.
  • Heraganahally SS, Silva SAMS, Howarth TM, Kangaharan N, Majoni SW. Comparison of clinical manifestation among Australian Indigenous and non‐ Indigenous patients presenting with pleural effusion. Int Med J. 2021. doi:10.1111/imj.15310
  • Heraganahally SS, Mortimer N, Howarth T, et al. Utility and outcomes among Indigenous and non-Indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population. Aust J Rural Health. 2021;29(6):918–926. doi:10.1111/ajr.12782
  • Heraganahally SS, Kruavit A, Oguoma VM, et al. Sleep apnoea among Australian Aboriginal and Non- Aboriginal patients in the Northern Territory of Australia– a comparative study. Sleep. 2020;43(3):zsz248. doi:10.1093/sleep/zsz248
  • Mehra S, Ghimire RH, Mingi JJ, et al. Gender differences in the clinical and polysomnographic characteristics among Australian aboriginal patients with obstructive sleep apnea. Nat Sci Sleep. 2020;12:593–602. doi:10.2147/NSS.S258330
  • Garg H, Er XY, Howarth T, Heraganahally SS. positional sleep apnea among regional and remote Australian population and simulated positional treatment effects. Nat Sci Sleep. 2020;12:1123–1135. doi:10.2147/NSS.S286403
  • Heraganahally SS, Kerslake C, Issac S, et al. Outcome of public hospital-funded continuous positive airway therapy device for patients with obstructive sleep apnoea: an Australian perspective study. Sleep Vigilance. 2020;4(2):195–204. doi:10.1007/s41782-020-00114-4
  • Heraganahally SS, Zaw KK, Tip S, et al. Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women. Int Med J. 2022;52(3):440–450. doi:10.1111/imj.15076
  • Heraganahally SS, Rajaratnam B, Silva SAAS, et al. Obstructive sleep apnoea and cardiac disease among aboriginal patients in the Northern Territory of Australia. Heart Lung Circ. 2021;30(8):1184–1192. doi:10.1016/j.hlc.2021.01.007
  • Benn E, Wirth H, Short T, Howarth T, Heraganahally SS. The Top End Sleepiness Scale (TESS): a new tool to assess subjective daytime sleepiness among indigenous Australian adults. Nat Sci Sleep. 2021;13:315–328. doi:10.2147/NSS.S298409
  • Heraganahally SS, Howarth TP, Wirth H, Short T, Benn E. Validity of the New “Top End Sleepiness Scale” (TESS) against the STOP-bang tool in predicting obstructive sleep apnoea among Indigenous Australian Adults. Intern Med J. 2021. doi:10.1111/imj.15633
  • Heraganahally SS, White S. A cost-effective novel innovative box (C-box) to prevent cockroach infestation of continuous positive airway pressure equipment: a unique problem in Northern Tropical Australia. Am J Trop Med Hyg. 2019;101(4):937–940. doi:10.4269/ajtmh.19-0434
  • Heraganahally SS, Ghimire RH, Howarth T, Kankanamalage OM, Palmer D, Falhammar H. Comparison and outcomes of emergency department presentations with respiratory disorders among Australian Indigenous and non-Indigenous Patients. BMC Emerg Med. 2022;22(1):11. doi:10.1186/s12873-022-00570-3
  • Heraganahally SS, Howarth T, Sorger L, Ben Saad H. Sex differences in pulmonary function parameters among Indigenous Australians with and without chronic airway disease. PLoS One. 2022;17(2):e0263744. doi:10.1371/journal.pone.0263744
  • Closing the Gap: Indigenous Health Campaign. Closing the gap in partnership: everyone enjoys long and healthy lives. Canberra: Australian Human Rights Commission; March 18, 2021. [ cited May 4, 2021]. Available from: https://www.closingthegap.gov.au/everyone-enjoys-long-and-healthy-lives.